Research graph
References from Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Disease without Pulmonary Hypertension: Prevalence and Clinical Impact in a Dutch Cohort. Local targets link to admitted publications; unresolved targets remain external evidence.
ERS statement on chronic thromboembolic pulmonary hypertension
10.1183/13993003.02828-2020 · 2021 · External reference
Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease
10.1183/13993003.00458-2018 · 2018 · External reference
2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension
10.1183/13993003.00879-2022 · 2023 · External reference
Chronic thromboembolic pulmonary hypertension
10.1056/nejmra010902 · 2001 · External reference
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry
10.1161/circulationaha.110.015008 · 2011 · External reference
Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study
10.1016/j.healun.2019.03.003 · 2019 · External reference
Clinical and radiologic characteristics of chronic thromboembolic pulmonary hypertension patients without a history of acute venous thromboembolism
10.1016/j.jtha.2025.02.033 · 2025 · External reference
Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism
10.1111/jth.14016 · 2018 · External reference
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis
10.1183/13993003.00449-2023 · 2023 · External reference
Epigenetic modification of the von Willebrand factor promoter drives platelet aggregation on the pulmonary endothelium in chronic thromboembolic pulmonary hypertension
10.1164/rccm.202109-2075oc · 2022 · External reference
Chronic thromboembolic pulmonary hypertension. Epidemiology and risk factors
10.1513/annalsats.201509-621as · 2016 · External reference
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis
2023 · External reference
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
10.1111/j.1538-7836.2006.01753.x · 2006 · External reference
Chronic thromboembolic pulmonary hypertension: a distinct disease entity
10.1183/16000617.00001115 · 2015 · External reference
2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension
10.1093/eurheartj/ehac237 · 2022 · External reference
2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
10.1093/eurheartj/ehz405 · 2020 · External reference
Surgical management of unresolved pulmonary embolism. A personal series of 72 patients
10.1378/chest.107.1_supplement.52s · 1995 · External reference
Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report
10.1016/s0002-9343(99)80187-9 · 1995 · External reference
Thrombotic risk factors in pulmonary hypertension
10.1034/j.1399-3003.2000.15b28.x · 2000 · External reference
Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension
10.1097/mbc.0b013e328331e664 · 2010 · External reference
Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy
10.1510/icvts.2009.221630 · 2010 · External reference
Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: results from the Korean registry
10.3904/kjim.2014.122 · 2016 · External reference
Thrombophilic factors in chronic thromboembolic pulmonary hypertension
10.1097/00001721-200109000-00002 · 2001 · External reference
Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension
1998 · External reference
Antiphospholipid syndrome in chronic thromboembolic pulmonary hypertension: a well-defined subgroup of patients
10.1055/s-0039-1692428 · 2019 · External reference
Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis
10.1007/s11739-018-02021-z · 2019 · External reference
Epidemiology of venous thromboembolism
10.1038/nrcardio.2015.83 · 2015 · External reference
Higher incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism in Asians than in Europeans: a meta-analysis
10.3389/fmed.2021.721294 · 2021 · External reference
Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort study
10.1097/md.0b013e31829cae47 · 2013 · External reference
High antiphospholipid antibody titers and outcomes of pulmonary endarterectomy: a single-center retrospective observational cohort study
10.1016/j.healun.2025.08.017 · 2025 · External reference
Pulmonary endarterectomy in antiphospholipid syndrome: a retrospective analysis from the Saudi pulmonary hypertension registry
10.3389/fmed.2026.1736115 · 2026 · External reference
Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations
2002 · External reference
Guidance from the scientific and standardization committee for lupus anticoagulant/antiphospholipid antibodies of the international society on thrombosis and haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation
10.1111/jth.15047 · 2020 · External reference
Pulmonary endarterectomy: experience and lessons learned in 1,500 cases
10.1016/s0003-4975(03)00828-2 · 2003 · External reference
Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry
10.1016/j.jtcvs.2010.11.024 · 2011 · External reference
Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the Netherlands
10.1007/s12471-019-01352-6 · 2020 · External reference
Long-term effects of pulmonary endarterectomy on right ventricular stiffness and fibrosis in chronic thromboembolic pulmonary hypertension
10.1161/circheartfailure.122.010336 · 2023 · External reference
Long-term effects of pulmonary endarterectomy on pulmonary hemodynamics, cardiac function, and exercise capacity in chronic thromboembolic pulmonary hypertension
10.1016/j.healun.2023.11.011 · 2024 · External reference
Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension
10.1183/16000617.0111-2016 · 2017 · External reference
Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism
10.1111/jth.14720 · 2020 · External reference
Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial
10.7326/m19-0291 · 2019 · External reference
RAPS trial investigators. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
10.1016/s2352-3026(16)30079-5 · 2016 · External reference
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
10.1182/blood-2018-04-848333 · 2018 · External reference
Review of functional status and hemodynamic parameters in patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH) with and without antiphospholipid syndrome (APLS)
10.1016/j.cpcardiol.2022.101154 · 2023 · External reference
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
10.1182/blood-2002-02-0441 · 2003 · External reference
Pulmonary endarterectomy in patients with antiphospholipid syndrome-associated chronic thromboembolic pulmonary hypertension
10.5152/anatoljcardiol.2021.1138 · 2022 · External reference
Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy
10.1093/ejcts/ezt572 · 2014 · External reference
Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study
10.1177/0961203318810427 · 2018 · External reference
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder
10.1101/2025.11.07.687095 · 2025 · External reference
Comments and opinions regarding “high antiphospholipid antibody titers and outcomes of pulmonary endarterectomy: a single-center retrospective observational cohort study” by Miard et al.
10.1016/j.healun.2026.02.1669 · 2026 · External reference
Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: risk factors and management
10.1016/j.healun.2021.10.016 · 2022 · External reference
An update on inflammation in antiphospholipid syndrome
10.1097/bor.0000000000000926 · 2023 · External reference
Antiphospholipid syndrome: a comprehensive clinical review
10.3390/jcm14030733 · 2025 · External reference
In situ pulmonary arterial thrombosis: literature review and clinical significance of a distinct entity
10.2214/ajr.23.28996 · 2023 · External reference
The pathogenesis of the antiphospholipid syndrome
10.1056/nejmra1112830 · 2013 · External reference
The significance of CD16+ monocytes in the occurrence and development of chronic thromboembolic pulmonary hypertension: insights from single-cell RNA sequencing
10.3389/fimmu.2024.1446710 · 2024 · External reference
Neutrophil extracellular traps promote fibrous vascular occlusions in chronic thrombosis
10.1182/blood.2020005861 · 2021 · External reference
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: a systematic review and meta-analysis
10.1016/j.autrev.2017.04.003 · 2017 · External reference
